Annual report pursuant to Section 13 and 15(d)

Stock Based Compensation (Details)

v3.22.1
Stock Based Compensation (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Number of shares    
Number of shares, Beginning balance 16,218,326 12,553,326
Number of shares, Grants 2,350,000 4,425,000
Number of shares, Exercises (250,000) (1,500)
Number of shares, Expiration   (758,500)
Number of shares, Ending balance 18,318,326 16,218,326
Options exercisable, Ending balance 18,318,326 16,093,326
Weighted Average Exercise Price    
Weighted Average Exercise Price, Beginning balance $ 0.50 $ 0.55
Weighted Average Exercise Price, Grants 0.78 0.38
Weighted Average Exercise Price, Exercises 0.55 0.17
Weighted Average Exercise Price, Expiration   0.68
Weighted Average Exercise Price, Ending balance 0.53 0.50
Options exercisable, Ending balance $ 0.53 $ 0.50
Weighted Average Remaining Contractual Life (years)    
Weighted Average Remaining Contractual Life (years), Beginning balance 3 years 6 months 26 days 4 years 7 days
Weighted Average Remaining Contractual Life (years), Grants 5 years 4 years 8 months 23 days
Weighted Average Remaining Contractual Life (years), Ending balance 2 years 10 months 20 days 3 years 6 months 25 days
Options exercisable, Ending balance 2 years 10 months 20 days 3 years 6 months 21 days
Aggregate Intrinsic Value    
Aggregate Intrinsic Value, Beginning balance $ 3,588,631 $ 927
Aggregate Intrinsic Value, Ending balance 2,961,965 3,588,631
Options exercisable, Ending balance, Intrinsic value $ 2,961,965 $ 3,532,381